Company intelligence
Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients with systemic amyloidosis.
Biotechnology Research
Naples, US
21 employees
1 public signals
About Attralus
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.
Verified activity
Signals from Attralus
1 published signal